Literature DB >> 22933177

Adjuvant mitomycin C in functional endoscopic sinus surgery.

Marco Carifi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22933177     DOI： 10.1007/s00405-012-2164-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  6 in total

1.  The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?

Authors:  Claire Hopkins; John P Browne; Rob Slack; Valerie Lund; Peter Brown
Journal:  Otolaryngol Head Neck Surg       Date:  2007-10       Impact factor: 3.497

2.  Surgical causes of failure in endoscopic sinus surgery.

Authors:  H H Ramadan
Journal:  Laryngoscope       Date:  1999-01       Impact factor: 3.325

3.  Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts.

Authors:  D Hu; B S Sires; D C Tong; G A Royack; D Oda
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2000-03       Impact factor: 1.746

4.  Histopathologic effects of mitomycin-C on endoscopic transnasal dacryocystorhinostomy.

Authors:  S H Ugurbas; G Zilelioglu; M F Sargon; Y Anadolu; M Akiner; T Aktürk
Journal:  Ophthalmic Surg Lasers       Date:  1997-04

5.  Topical Mitomycin C in functional endoscopic sinus surgery.

Authors:  Vaidyanathan Venkatraman; Deepak Balasubramanian; Suria Gopalakrishnan; Sunil Kumar Saxena; Nirmal Shanmugasundaram
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-13       Impact factor: 2.503

6.  Clinical prognostic factors of chronic rhinosinusitis after endoscopic sinus surgery.

Authors:  Yuan Li; Ge-hua Zhang; Xian Liu; Jin Ye; Zhuan-ping Zeng
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2008-04-15       Impact factor: 1.538
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.